Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The company is headquartered in Vantaa, Etela-Suomen and currently employs 247 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
How did REVXF's recent EPS compare to expectations?
The most recent EPS for Revenio Group Oyj is $0.2, not beating expectations of $0.25.
How did Revenio Group Oyj REVXF's revenue perform in the last quarter?
Revenio Group Oyj revenue for the last quarter is $0.2
What is the revenue estimate for Revenio Group Oyj?
According to 7 of Wall street analyst, the revenue estimate of Revenio Group Oyj range from $29.4M to $26.46M
What's the earning quality score for Revenio Group Oyj?
Revenio Group Oyj has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Revenio Group Oyj report earnings?
Revenio Group Oyj next earnings report is expected in 2026-05-12
What are Revenio Group Oyj's expected earnings?
Revenio Group Oyj expected earnings is $33.04M, according to wall-street analysts.
Did Revenio Group Oyj beat earnings expectations?
Revenio Group Oyj recent earnings of $31.2M does not beat expectations.